Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Therapy Name||GBM6-AD lysate protein vaccine + Poly ICLC|
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|GBM6-AD lysate protein vaccine||GBM6-AD||GBM6-AD lysate protein vaccine comprises cell lysate obtained from the brain tumor initiating cell line GBM6-AD, which has potential antitumor activity (Neuro-Oncology, Vol. 19, Issue suppl_6, Page vi28).|
|Poly ICLC||Hiltonol||Hiltonol (poly ICLC) is a synthetic double stranded RNA complex, which induces interferon production and stimulates anti-tumor immune response (PMID: 22126373).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|
|NCT02549833||Phase I||GBM6-AD lysate protein vaccine + Poly ICLC||Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma||Recruiting|